Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'

被引:0
|
作者
Kermani, Tanaz A. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Rheumatol, Los Angeles, CA 90095 USA
关键词
COVID-19; systemic vasculitis; biological therapy;
D O I
10.1136/annrheumdis-2021-219879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
    Avouac, Jerome
    Drumez, Elodie
    Hachulla, Eric
    Seror, Raphaele
    Georgin-Lavialle, Sophie
    El Mahou, Soumaya
    Pertuiset, Edouard
    Thao Pham
    Marotte, Hubert
    Servettaz, Amelie
    Domont, Fanny
    Chazerain, Pascal
    Devaux, Mathilde
    Claudepierre, Pascal
    Langlois, Vincent
    Mekinian, Arsene
    Maria, Alexandre Thibault Jacques
    Banneville, Beatrice
    Fautrel, Bruno
    Pouchot, Jacques
    Thomas, Thierry
    Flipo, Rene-Marc
    Richez, Christophe
    LANCET RHEUMATOLOGY, 2021, 3 (06): : E419 - E426
  • [22] Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'
    Aydin, Sibel Zehra
    Hepworth, Elliot
    Tugwell, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03) : E69 - E69
  • [23] Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'
    Schulze-Koops, Hendrik
    Skapenko, Alla
    Krause, Andreas
    Krueger, Klaus
    Lorenz, Hanns-Martin
    Sewerin, Philipp
    Specker, Christof
    Wagner, Ulf G.
    Voormann, Anna
    Mueller-Ladner, Ulf
    Voll, Reinhard E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01)
  • [24] New data emerging on outcomes for patients with COVID-19 and rheumatic diseases
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (08) : 407 - 407
  • [25] New data emerging on outcomes for patients with COVID-19 and rheumatic diseases
    Sarah Onuora
    Nature Reviews Rheumatology, 2020, 16 : 407 - 407
  • [26] Evolution of COVID-19 in patients with autoimmune rheumatic diseases
    Pang, Rongrong
    Zhao, Jun
    Gan, Zhenhua
    Hu, Zhiliang
    Xue, Xiang
    Wu, Yanjun
    Qiao, Qinghua
    Zhong, Aifang
    Xia, Xinyi
    Liao, Hui
    Wang, Zhihua
    Zhang, Libo
    AGING-US, 2020, 12 (23): : 23427 - 23435
  • [27] COVID-19 in Pregnant Patients with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance
    Bermas, Bonnie
    Clowse, Megan
    Gianfrancesco, Milena
    Hausmann, Jonathan
    Machado, Pedro M.
    Sirotich, Emily
    Robinson, Helen
    Strangfeld, Anja
    Yazdany, Jinoos
    Robinson, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] Cardiovascular manifestations in patients with rheumatic diseases and COVID-19
    Villafuerte Morales, Johanna Elizabeth
    Hernandez Batista, Sulema de la Caridad
    Chimbolema Mullo, Sergio Orlando
    Pilamunga Lema, Cesar Lenin
    REVISTA CUBANA DE REUMATOLOGIA, 2021, 23 (01):
  • [29] COVID-19 in Patients With Rheumatic Diseases Is There a Need to Worry?
    Sachdeva, Sonali
    Manaktala, Pritika
    Malik, Faizan Ahmad
    Gupta, Udita
    Desai, Rupak
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E401 - E406
  • [30] Autoantibodies in patients with diagnosis of COVID-19 and rheumatic diseases
    Camacho Abarca, Evelyn Margarita
    Llerena Flores, Gabriela Estefania
    Tixi Berrones, Nathaly Silvana
    Quishpe Chirau, Sara Marina
    Quijosaca Cajilema, Luis Alberto
    REVISTA CUBANA DE REUMATOLOGIA, 2021, 23 (01):